Listen to a recording of the July 2020 Scientific Update Meeting Listen to M4K Pharma’s Scientific Update Meeting from July 15th, 2020 where our scientists and collaborators discuss the latest progress in our Medicines4Kids project for a deadly children’s brain cancer called DIPG. Everyone is invited to hear first-hand how we are [...]
Fostering open collaboration in drug development for paediatric brain tumours Wong et al. describe in Biochemical Society Transactions how open collaboration and an open drug discovery model, like the one used by M4K Pharma, can help overcome the challenges faced while researching therapies for rare paediatric brain tumours such as DIPG. Prognosis of childhood brain [...]
Listen to a recording of the May 2019 Scientific Update Meeting Listen to M4K Pharma's Scientific Update Meeting from May 8th, 2019 where our scientists and collaborators discuss the latest progress in our Medicines4Kids project for a deadly children's brain cancer called DIPG. Everyone is invited to hear first-hand how we are [...]
Study published on new drug class targeting ACVR1 mutation for DIPG Scientists at The Institute of Cancer Research, London, along with colleagues at the Structural Genomics Consortium in Oxford, have published their findings on a new drug class that can kill brain cancer cells with mutations in the ACVR1 gene and shrink tumours in mice. Mutated versions [...]
Listen to a recording of the April 24th 2019 Scientific Update Meeting Listen to our scientists and collaborators discuss the latest progress in M4K Pharma’s quest for a medicine for DIPG- a deadly children’s brain cancer. Everyone is invited to dial-in and join our live meetings. To find out when our next [...]
Recording of M4K Pharma's Scientific Update Meeting - December 4th, 2018 Listen to our scientists and collaborators discuss the latest progress in M4K Pharma's quest for a medicine for DIPG- a deadly children's brain cancer. In this meeting, the team provides a comprehensive summary of the project accomplishments at the one year [...]
Recording of M4K Pharma's Scientific Update Meeting - August 15th, 2018. Listen to our scientists and collaborators discuss the latest progress in M4K Pharma's quest for a medicine for DIPG- a deadly children's brain cancer. Everyone is invited to dial-in and join the live meetings. To find out when our next meeting will be, follow [...]
Recording of M4K Pharma's Scientific Update Meeting - July 18th, 2018. Listen to our scientists and collaborators discuss the latest progress in M4K Pharma's quest for a medicine for DIPG- a deadly children's brain cancer. Everyone is invited to dial-in and join the live meetings. To find out when our next meeting will be, follow [...]
M4K Pharma's Lemon Face Challenge for DIPG Watch the M4K team in Toronto complete the #LemonFaceChallenge to spread DIPG awareness, along with the Structural Genomics Consortium (SGC) and the Ontario Institute for Cancer Research (OICR). Charles River Laboratories met our challenge to them with their own lemon faces in this video here: https://twitter.com/hamblin_nicole/status/989234916872327170 [...]
[Podcast] Bio2040 interviews M4K Pharma's Owen Roberts In a podcast interview with Bio2040, CEO Owen Roberts discusses M4K Pharma's business model and why open science and sharing can be the path to finding medicines for rare diseases like DIPG.
